Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 33.75% |
| Q2 2025 | 5.90% |
| Q1 2025 | -2.77% |
| Q4 2024 | 25.18% |
| Q3 2024 | -6.44% |
| Q2 2024 | -5.73% |
| Q1 2024 | 23.56% |
| Q4 2023 | 7.31% |
| Q3 2023 | 15.69% |
| Q2 2023 | -88.46% |
| Q1 2023 | 18.67% |
| Q4 2022 | -130.94% |
| Q3 2022 | 34.18% |
| Q2 2022 | 27.49% |
| Q1 2022 | -99.87% |
| Q4 2021 | -61.68% |
| Q3 2021 | -41.71% |
| Q2 2021 | -69.43% |
| Q1 2021 | 37.71% |
| Q4 2020 | -131.21% |
| Q3 2020 | 22.59% |
| Q2 2020 | -13.68% |
| Q1 2020 | -647.45% |
| Q4 2019 | -50.13% |
| Q3 2019 | -18.94% |
| Q2 2019 | 207.37% |
| Q1 2019 | -219.74% |
| Q4 2018 | 1388.22% |
| Q3 2018 | 232.58% |
| Q2 2018 | 0.00% |